April 10, 2014
Chuikyo Meeting The Central Social Insurance Medical Council known as Chuikyo on April 9 approved the listing of 14 active pharmaceutical ingredients (APIs)/27 products, including Japan’s first sodium-glucose co-transporter-2 (SGLT-2) inhibitor Suglat (ipragliflozin), the dysuria treatment Zalutia (tadalafil), and the...read more